Runfeng Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Runfeng Chen has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- An Qin
Department of Orthopaedics, Shanghai Key Laboratory of Orthopaedic Implant, Shanghai Ninth People' s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China
1 shared publication - Baoqiang Li
Institute for Advanced Ceramics State Key Laboratory of Urban‐rural Water Resource and Environment Harbin Institute of Technology Harbin P. R. China
1 shared publication Guanxiong Liu
Institute for Advanced Ceramics; State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology, Harbin 150001, China
1 shared publicationJinmin Zhao
Guangxi Key Laboratory of Regenerative Medicine, Guangxi Medical University, Guangxi, China
1 shared publicationQian Liu
Guangxi Key Laboratory of Regenerative Medicine, Guangxi Medical University, Guangxi, China
1 shared publicationWenxin He
Shanghai Key Laboratory of Orthopaedic Implants
1 shared publication
Latest Publications
- 30 June 2020
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 12 (30) , 16229-16244
Chitosan derived nitrogen-doped carbon dots suppress osteoclastic osteolysisviadownregulating ROS
Osteoclasts are the main cells involved in normal bone remodeling and pathological bone destruction in vivo. Overactivation of osteoclasts can lead to osteolytic diseases, including breast cancer, bone tumors, arthritis, the aseptic loosening of orthopedic implants, and Paget's disease. Excessive reactive oxygen species are the main cause of osteoclast overactivation. We have synthesized chitosan derived nitrogen-doped carbon dots (N-CDs) with a high synthetic yield and the ability to scavenge reactive oxygen species (ROS). N-CDs effectively abrogated RANKL-induced elevation in ROS generation and therefore impaired the activation of NF-κB and MAPK pathways. Osteoclastogenesis and bone resorption was effectively attenuated in vitro. Furthermore, the in vivo administration of N-CDs in mice protected them against lipopolysaccharide (LPS)-induced calvarial bone destruction and breast cancer cell-induced tibial bone loss. Based on the good biocompatibility of N-CDs and the ability to efficiently remove ROS, a nanomaterial treatment scheme was provided for the first time for the clinical treatment of osteolytic diseases.
- 30 June 2020
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 12 (30) , 16229-16244
Chitosan derived nitrogen-doped carbon dots suppress osteoclastic osteolysisviadownregulating ROS
Osteoclasts are the main cells involved in normal bone remodeling and pathological bone destruction in vivo. Overactivation of osteoclasts can lead to osteolytic diseases, including breast cancer, bone tumors, arthritis, the aseptic loosening of orthopedic implants, and Paget's disease. Excessive reactive oxygen species are the main cause of osteoclast overactivation. We have synthesized chitosan derived nitrogen-doped carbon dots (N-CDs) with a high synthetic yield and the ability to scavenge reactive oxygen species (ROS). N-CDs effectively abrogated RANKL-induced elevation in ROS generation and therefore impaired the activation of NF-κB and MAPK pathways. Osteoclastogenesis and bone resorption was effectively attenuated in vitro. Furthermore, the in vivo administration of N-CDs in mice protected them against lipopolysaccharide (LPS)-induced calvarial bone destruction and breast cancer cell-induced tibial bone loss. Based on the good biocompatibility of N-CDs and the ability to efficiently remove ROS, a nanomaterial treatment scheme was provided for the first time for the clinical treatment of osteolytic diseases.